Clinical TrialsSearch results
Number of results: 616
Other
- Multicenter Phase II Study of Combination Epitope Peptides with mFOLFOX6 in Advanced/metastatic Colorectal Cancer
- Metastatic chemo naive colorectal cancer
- YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology
- 2009-05-01
Completed
- I-125 permanent brachytherapy
- Prostate cancer
- Yamada Yasuhiro
- 2019-03-22
Recruiting
- Ramucirumab and Erlotinib in EGFR Exon 19 Deletion or L858R mutation Positive Treatment-naive Non-Small Cell Lung Cancer with High PD-L1 Expression
- non-small Cell Lung Cancer
- Yamada Tadaaki
- 2023-01-12
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Recruiting
- AML-SCT15
- acute myeloid leukemia (AML)
- YABE Hiromasa
- 2019-03-26
Not yet recruiting
- Phase 1/1b study to evaluate the safety of OZTx-410 in individuals with type 1 diabetes eligible for pancreatic islet transplantation
- Type 1 Diabetes
- Yabe Daisuke
- 2024-10-03
Other
- A Randomized Phase III trial of chemotherapy alone versus chemotherapy followed by gefitinib in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV Non-small cell lung cancer
- West Japan Thoracic Oncology Group (WJTOG)
- 2005-09-04
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30